GEICAM/2009-03 (ConvertHER) Study
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001866.v1.p1
下载链接
链接失效反馈官方服务：
资源简介：
The goal of this study is to capture the transcriptome landscape of luminal and basal-like metastatic breast tumors. We will aim to show the importance of using the most up-to-date cancer biopsy for detecting cancer drivers that were often not present in the primary tumor.]]>
Successfully-sequenced samples from participants of the GEICAM/2009-03 (ConvertHER) Study.]]>
The RNA sequence-based analysis used to compare breast primary and metastatic tumor pairs study looks at a subset of the 236 patients recruited to GEICAM/2009-03. The "Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis," or the "GEICAM/2009-03 (ConvertHER) Study," ClinicalTrials.gov: NCT01377363, is a prospective clinical trial without drugs, to determine the HER2 status in the metastasis of patients with primary breast cancer. 236 patients were recruited and 32 sites took part in this clinical trial. Study Start: December 2009]]>
创建时间：
2019-07-12
